Advanced Knowledge
for Attorneys and CPAs

October 4, 2023 Tomorrow

• Appealing IRS Penalty Abatement Denials
• Utility-Related Injuries and Fatalities
• Employer DEI Initiatives: Students for Fair Admissions
• Shareholder Activism in M&A: Preparing for Activist Attacks
• Insurance Neutrality in Chapter 11 Plans

October 5, 2023 in 1 day

• GRATs in Estate Planning Under Current Tax Law
• Structuring Corporate PPAs for Renewable Energy
• Advanced Income Tax Apportionment Issues
• Mezzanine Foreclosure in Real Estate Finance
• Private Equity Compliance With ERISA
• EU Guidelines for Patenting AI and ML Technologies
• Data Breach and Privacy Class Actions: New Lessons
• Healthcare M&A Transactions Under Heightened State and Federal Scrutiny

October 10, 2023 in 7 days

• Trust Dispositions of IRAs and Qualified Plans
• Conservation Easement Tax Issues
• Consumer Data Transfers Under New Privacy Laws
• Healthcare Antitrust: New DOJ and FTC Merger Guidelines
• Drafting Asset Purchase Agreements
• Deeds in Lieu of Foreclosure: Advantages, Disadvantages
• Acquired Distinctiveness in the EU After the Louis Vuitton Case
• Persuasion Principles for Trial Lawyers

October 11, 2023 in 8 days

• Patent Drafting for Multiple Jurisdictions
• Renewable Energy Projects: REC Purchase and Sale
• Expert Witness Depositions
• Duty to Mitigate Damages in Employment Cases
• Managing IP While Using Open Source
• Protecting the Spouse in Long-Term Medicaid Planning

October 12, 2023 in 9 days

• Subordination, Non-Disturbance, and Attornment Agreements
• Labeling and Infringement in Pharma Patent Litigation
• Opinions of Counsel in Lending Transactions
• HHS-OIG’s New Health Information Blocking Rule
• SEC's New Cybersecurity Disclosure Rules
• 401(k) Plan Challenges for Small Businesses
• Advanced Estate Planning for Large Estates

October 16, 2023 in 13 days

• Qualified Opportunity Zones: Working Capital Safe Harbor
• Obviousness-Type Double Patenting, PTA, and PTEs

October 17, 2023 in 14 days

• Alternative Apportionment: Requesting Relief
• 401(k) Plan Issues in Stock Purchase M&A Transactions
• Conducting Clinical Trials Outside the U.S.
• Construction Site Injury Litigation
• Discovery in Bad Faith Insurance Litigation
• Virtual Patent Marking: Practical Considerations
• PAGA Employment Claims: Arbitration; Penalties
• Foreign Late Filing Notices
• EPA Elimination of CAA Affirmative Defenses
• Net Asset Value (NAV) Financing in Private Equity
• U.S.-Australia Tax Issues for Dual Status Taxpayers
• Offshore Asset Protection Trusts